Skip to main content
. Author manuscript; available in PMC: 2009 Jul 20.
Published in final edited form as: Cancer Lett. 2007 Mar 8;253(2):258–264. doi: 10.1016/j.canlet.2007.01.023

Table 2.

Positive predictive values of FOBT alone or in combination with stool K-ras results, for the detection of malignancies, adenomas, any tumors or benign non-neoplastic findings in the colon

Findings in colon Any FOBT+ FOBT+ >4 fields Any K-ras+ In FOBT+ FOBT>4 + K-ras+
 N 130 41 32 10
Adenocarcinoma 23 13 8 6
PPV 17.7% (2.1–33.3) 31.7% (12.7–50.7) 25.0% (7.3–42.7) 60.0% (40.0–80.0)
Adenoma 25 9 8 2
PPV 19.2% (3.8–34.7) 22.0% (5.7–38.2) 25.0% (8.0–42.0) 20.0% (4.3–35.7)
All Neoplasms* 62 25 17 8
PPV 47.7% (35.3–60.1) 61.0% (48.8–73.1) 53.1% (40.7–65.5) 80.0% (70.0–90.0)
No-neoplastic GI disease** 46 13 9 1
PPV 35.4% (21.6–49.2) 31.7% (18.3–45.2) 28.1% (15.1–41.1) 10.0% (1.3–18.7)
Normal colonoscopy*** 22 3 6 1
PPV 16.9% 7.3% 18.8% 10.0%
*

Includes adenocarcinomas, adenomas and polyps NOS

**

Includes diverticulosis, hemorrhoids, IBD.

***

does not preclude upper GI findings